应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RLYB Rallybio Corp.
休市中 07-11 16:00:00 EDT
0.4062
+0.0102
+2.58%
盘后
0.4400
+0.0338
+8.32%
19:59 EDT
最高
0.4250
最低
0.3600
成交量
85.25万
今开
0.3875
昨收
0.3960
日振幅
16.41%
总市值
1,690万
流通市值
799.68万
总股本
4,161万
成交额
33.40万
换手率
4.33%
流通股本
1,969万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Rallybio Corporation盘中异动 急速跳水9.07%
市场透视 · 07-11 13:32
Rallybio Corporation盘中异动 急速跳水9.07%
Rallybio Corporation盘中异动 大幅下挫6.94%
市场透视 · 07-10 13:31
Rallybio Corporation盘中异动 大幅下挫6.94%
Rallybio Corporation盘中异动 早盘股价大跌5.16%
市场透视 · 07-09 13:31
Rallybio Corporation盘中异动 早盘股价大跌5.16%
万春医药盘中异动 大幅拉升5.73%
市场透视 · 07-08
万春医药盘中异动 大幅拉升5.73%
Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 大幅下挫30.00%
市场透视 · 07-08
Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 大幅下挫30.00%
Mimedx Group, Inc盘中异动 股价大涨5.09%报6.81美元
市场透视 · 07-08
Mimedx Group, Inc盘中异动 股价大涨5.09%报6.81美元
Maravai Lifesciences Holdings, Inc.盘中异动 快速上涨5.00%
市场透视 · 07-08
Maravai Lifesciences Holdings, Inc.盘中异动 快速上涨5.00%
木薯科学盘中异动 早盘大幅拉升5.18%
市场透视 · 07-08
木薯科学盘中异动 早盘大幅拉升5.18%
Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.04%报1.25美元
市场透视 · 07-08
Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.04%报1.25美元
Nucana Plc盘中异动 早盘股价大涨5.01%
市场透视 · 07-08
Nucana Plc盘中异动 早盘股价大涨5.01%
Acurx Pharmaceuticals, Inc.盘中异动 快速上涨5.64%
市场透视 · 07-08
Acurx Pharmaceuticals, Inc.盘中异动 快速上涨5.64%
Rallybio Corporation盘中异动 急速拉升5.92%
市场透视 · 07-07
Rallybio Corporation盘中异动 急速拉升5.92%
Rallybio Corporation盘中异动 早盘急速下跌5.35%
市场透视 · 06-27
Rallybio Corporation盘中异动 早盘急速下跌5.35%
Rallybio Corporation盘中异动 股价大跌5.35%
市场透视 · 06-25
Rallybio Corporation盘中异动 股价大跌5.35%
Rallybio Corporation盘中异动 大幅拉升10.60%报0.339美元
市场透视 · 06-23
Rallybio Corporation盘中异动 大幅拉升10.60%报0.339美元
Rallybio Corporation盘中异动 股价大跌5.77%
市场透视 · 06-20
Rallybio Corporation盘中异动 股价大跌5.77%
Rallybio Corporation盘中异动 早盘急速上涨5.43%
市场透视 · 06-16
Rallybio Corporation盘中异动 早盘急速上涨5.43%
Rallybio Corporation盘中异动 早盘快速跳水5.67%报0.336美元
市场透视 · 06-12
Rallybio Corporation盘中异动 早盘快速跳水5.67%报0.336美元
Rallybio Corporation盘中异动 股价大涨6.46%
市场透视 · 06-10
Rallybio Corporation盘中异动 股价大涨6.46%
Rallybio Corporation盘中异动 早盘急速下挫6.25%报0.370美元
市场透视 · 06-09
Rallybio Corporation盘中异动 早盘急速下挫6.25%报0.370美元
加载更多
公司概况
公司名称:
Rallybio Corp.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Rallybio Corporation于2018年3月22日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,由经验丰富的生物制药行业领导者组成,拥有广泛的研究、开发和罕见疾病专业知识,其使命是为患有严重和罕见疾病的患者开发和商业化改变生命的疗法。自公司于2018年1月推出以来,该公司已经建立了广泛的有前景的候选产品管道,旨在解决孕产妇胎儿健康、补体失调、血液学和代谢紊乱等领域存在未满足医疗需求的疾病。该公司两个最先进的项目正在临床开发中:RLYB212,一种用于预防胎儿和新生儿同种免疫性血小板减少症(“FNAIT”)的抗HPA-1a抗体,以及RLYB116,一种补体成分5(“C5”)的抑制剂,具有治疗几种补体失调疾病的潜力。
发行价格:
--
{"stockData":{"symbol":"RLYB","market":"US","secType":"STK","nameCN":"Rallybio Corp.","latestPrice":0.4062,"timestamp":1752264000000,"preClose":0.396,"halted":0,"volume":852477,"hourTrading":{"tag":"盘后","latestPrice":0.44,"preClose":0.4062,"latestTime":"19:59 EDT","volume":18296,"amount":7469.4187,"timestamp":1752278382581},"delay":0,"floatShares":19686929,"shares":41613964,"eps":-1.081713,"marketStatus":"休市中","change":0.0102,"latestTime":"07-11 16:00:00 EDT","open":0.3875,"high":0.425,"low":0.36,"amount":334020.1808187,"amplitude":0.164141,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.081713,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"listingDate":1627531200000,"exchange":"NASDAQ","adjPreClose":0.396,"preHourTrading":{"tag":"盘前","latestPrice":0.4,"preClose":0.396,"latestTime":"09:27 EDT","volume":17648,"amount":6746.14336336,"timestamp":1752240434552},"postHourTrading":{"tag":"盘后","latestPrice":0.44,"preClose":0.4062,"latestTime":"19:59 EDT","volume":18296,"amount":7469.4187,"timestamp":1752278382581},"volumeRatio":0.027028084208919743},"requestUrl":"/m/hq/s/RLYB","defaultTab":"news","newsList":[{"id":"2550959629","title":"Rallybio Corporation盘中异动 急速跳水9.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550959629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550959629?lang=zh_cn&edition=full","pubTime":"2025-07-11 21:32","pubTimestamp":1752240759,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日21时32分,Rallybio Corporation股票出现波动,股价急速下挫9.07%。截至发稿,该股报0.360美元/股,成交量7.6323万股,换手率0.18%,振幅1.24%。Rallybio Corporation股票所在的生物技术行业中,整体跌幅为0.63%。Rallybio Corporation公司简介:Rallybio Corp 是一家临床阶段的生物技术公司,致力于为严重和罕见疾病患者识别和加速开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711213239a6a3f98c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711213239a6a3f98c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RLYB","BK4139"],"gpt_icon":0},{"id":"2550256476","title":"Rallybio Corporation盘中异动 大幅下挫6.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550256476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550256476?lang=zh_cn&edition=full","pubTime":"2025-07-10 21:31","pubTimestamp":1752154278,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时31分,Rallybio Corporation股票出现波动,股价快速下挫6.94%。Rallybio Corporation股票所在的生物技术行业中,整体跌幅为0.14%。其相关个股中,Cognition Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Neonc Technologies Holdings, Inc.涨幅较大,Cognition Therapeutics, Inc.、Klotho Neurosciences, Inc.、Nucana Plc较为活跃,换手率分别为192.02%、115.45%、58.78%,振幅较大的相关个股有Cognition Therapeutics, Inc.、Nurix Therapeutics, Inc.、Nextcure, Inc.,振幅分别为13.34%、11.69%、11.47%。Rallybio Corporation公司简介:Rallybio Corp 是一家临床阶段的生物技术公司,致力于为严重和罕见疾病患者识别和加速开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213119a442b795&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213119a442b795&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RLYB"],"gpt_icon":0},{"id":"2550465872","title":"Rallybio Corporation盘中异动 早盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550465872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550465872?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:31","pubTimestamp":1752067863,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时31分,Rallybio Corporation股票出现波动,股价大幅下跌5.16%。Rallybio Corporation股票所在的生物技术行业中,整体涨幅为0.29%。其相关个股中,Calidi Biotherapeutics, Inc.、Prokidney Corp.、Kazia Therapeutics Limited涨幅较大,Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Entero Therapeutics Inc.较为活跃,换手率分别为576.30%、514.50%、388.42%,振幅较大的相关个股有Abvc Biopharma, Inc.、Artelo Biosciences, Inc.、Calidi Biotherapeutics, Inc.,振幅分别为10.42%、7.86%、7.25%。Rallybio Corporation公司简介:Rallybio Corp 是一家临床阶段的生物技术公司,致力于为严重和罕见疾病患者识别和加速开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213103953c33e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213103953c33e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RLYB","BK4539"],"gpt_icon":0},{"id":"2550527982","title":"万春医药盘中异动 大幅拉升5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550527982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550527982?lang=zh_cn&edition=full","pubTime":"2025-07-09 02:05","pubTimestamp":1751997953,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日02时05分,万春医药股票出现异动,股价大幅上涨5.73%。截至发稿,该股报2.40美元/股,成交量6850股,换手率0.02%,振幅6.61%。万春医药股票所在的生物技术行业中,整体涨幅为1.08%。万春医药公司简介:BeyondSpring Inc从事临床阶段的生物制药活动,专注于癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709020553a43e86b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709020553a43e86b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4539","BK4139","RLYB"],"gpt_icon":0},{"id":"2549525074","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 大幅下挫30.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549525074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549525074?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:51","pubTimestamp":1751986261,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日22时51分,Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现波动,股价急速下跌30.00%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中,整体涨幅为1.17%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介:SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司,专注于开发和商业化其专有免疫治疗平台的产品组合,以生产完全靶向的人多克隆抗体,而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708225101a43e4ff6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708225101a43e4ff6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLYB","SABSW","BK4139","BK4539"],"gpt_icon":0},{"id":"2549525090","title":"Mimedx Group, Inc盘中异动 股价大涨5.09%报6.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549525090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549525090?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:50","pubTimestamp":1751986228,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日22时50分,Mimedx Group, Inc股票出现波动,股价大幅上涨5.09%。截至发稿,该股报6.81美元/股,成交量25.3977万股,换手率0.17%,振幅5.48%。Mimedx Group, Inc股票所在的生物技术行业中,整体涨幅为1.11%。Mimedx Group, Inc公司简介:MiMedx Group Inc开发和销售再生生物材料产品和生物植入物,这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708225028a43e4fdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708225028a43e4fdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLYB","BK4139","MDXG","BK4539"],"gpt_icon":0},{"id":"2549352501","title":"Maravai Lifesciences Holdings, Inc.盘中异动 快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549352501","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549352501?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:48","pubTimestamp":1751986116,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日22时48分,Maravai Lifesciences Holdings, Inc.股票出现波动,股价急速拉升5.00%。Maravai Lifesciences Holdings, Inc.股票所在的生物技术行业中,整体涨幅为1.08%。Maravai Lifesciences Holdings, Inc.公司简介:Maravai LifeSciences Holdings Inc 是一家生命科学公司,提供关键产品,推动突破性疫苗、药物疗法、细胞和基因疗法以及诊断的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708224836a69d6a93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708224836a69d6a93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLYB","BK4139","BK4121","BK4539","MRVI"],"gpt_icon":0},{"id":"2549250725","title":"木薯科学盘中异动 早盘大幅拉升5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549250725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549250725?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:39","pubTimestamp":1751985580,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日22时39分,木薯科学股票出现异动,股价大幅拉升5.18%。截至发稿,该股报2.03美元/股,成交量22.1808万股,换手率0.46%,振幅4.66%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予持有建议,无券商给予买入、卖出建议。木薯科学股票所在的生物技术行业中,整体涨幅为1.07%。目前,该公司正在对阿尔茨海默氏症痴呆患者进行两项口服simufilam的随机安慰剂对照 3 期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223940a69d67da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223940a69d67da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","RLYB","BK4007","BK4547","BK4585","BK4139","SAVA","BK4539"],"gpt_icon":0},{"id":"2549817526","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.04%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549817526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549817526?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:31","pubTimestamp":1751985078,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日22时31分,Zentalis Pharmaceuticals, Inc.股票出现异动,股价快速上涨5.04%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.95%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司,开发 azenosertib ,这是一种潜在的同类首创和同类最佳 WEE1 抑制剂,用于 Cyclin E1 阳性铂耐药卵巢癌 患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223118a43e4913&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223118a43e4913&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLYB","BK4539","BK4139","ZNTL"],"gpt_icon":0},{"id":"2549252380","title":"Nucana Plc盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549252380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549252380?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:45","pubTimestamp":1751982316,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时45分,Nucana Plc股票出现波动,股价急速拉升5.01%。截至发稿,该股报0.052美元/股,成交量886.962万股,换手率2.32%,振幅9.62%。Nucana Plc股票所在的生物技术行业中,整体涨幅为0.41%。Nucana Plc公司简介:NuCana PLC是一家生物制药公司,专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药,旨在克服关键的抗癌机制,并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708214516a43e363b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708214516a43e363b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","NCNA","RLYB"],"gpt_icon":1},{"id":"2549552868","title":"Acurx Pharmaceuticals, Inc.盘中异动 快速上涨5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549552868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549552868?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:43","pubTimestamp":1751982182,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时43分,Acurx Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.64%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。Acurx Pharmaceuticals, Inc.公司简介:Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司,开发一类新型抗生素,用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708214303953ae763&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708214303953ae763&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RLYB","ACXP","BK4563"],"gpt_icon":0},{"id":"2549611555","title":"Rallybio Corporation盘中异动 急速拉升5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549611555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549611555?lang=zh_cn&edition=full","pubTime":"2025-07-07 22:35","pubTimestamp":1751898946,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日22时35分,Rallybio Corporation股票出现异动,股价大幅拉升5.92%。Rallybio Corporation股票所在的生物技术行业中,整体跌幅为0.23%。其相关个股中,Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.涨幅较大,Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃,换手率分别为4195.88%、1092.34%、818.71%,振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.,振幅分别为298.32%、93.67%、84.08%。Rallybio Corporation公司简介:Rallybio Corp 是一家临床阶段的生物技术公司,致力于为严重和罕见疾病患者识别和加速开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707223547979d251c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707223547979d251c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RLYB","BK4139"],"gpt_icon":0},{"id":"2546747591","title":"Rallybio Corporation盘中异动 早盘急速下跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546747591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546747591?lang=zh_cn&edition=full","pubTime":"2025-06-27 22:59","pubTimestamp":1751036384,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日22时59分,Rallybio Corporation股票出现波动,股价大幅下跌5.35%。截至发稿,该股报0.343美元/股,成交量5.2733万股,换手率0.13%,振幅8.55%。Rallybio Corporation股票所在的生物技术行业中,整体跌幅为0.02%。Rallybio Corporation公司简介:Rallybio Corp 是一家临床阶段的生物技术公司,致力于为严重和罕见疾病患者识别和加速开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627225945a4c17c36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627225945a4c17c36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RLYB","BK4539"],"gpt_icon":0},{"id":"2546245729","title":"Rallybio Corporation盘中异动 股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546245729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546245729?lang=zh_cn&edition=full","pubTime":"2025-06-25 21:44","pubTimestamp":1750859048,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日21时44分,Rallybio Corporation股票出现波动,股价快速下跌5.35%。截至发稿,该股报0.350美元/股,成交量2.9233万股,换手率0.07%,振幅4.46%。Rallybio Corporation股票所在的生物技术行业中,整体跌幅为0.52%。Rallybio Corporation公司简介:Rallybio Corp 是一家临床阶段的生物技术公司,致力于为严重和罕见疾病患者识别和加速开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214408978e83a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214408978e83a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RLYB","BK4539"],"gpt_icon":0},{"id":"2545448679","title":"Rallybio Corporation盘中异动 大幅拉升10.60%报0.339美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545448679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545448679?lang=zh_cn&edition=full","pubTime":"2025-06-23 22:04","pubTimestamp":1750687478,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日22时04分,Rallybio Corporation股票出现异动,股价大幅拉升10.60%。截至发稿,该股报0.339美元/股,成交量9055股,换手率0.02%,振幅2.97%。Rallybio Corporation股票所在的生物技术行业中,整体涨幅为0.44%。Rallybio Corporation公司简介:Rallybio Corp 是一家临床阶段的生物技术公司,致力于为严重和罕见疾病患者识别和加速开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623220439978b5db7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623220439978b5db7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RLYB","BK4139"],"gpt_icon":0},{"id":"2545787177","title":"Rallybio Corporation盘中异动 股价大跌5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545787177","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545787177?lang=zh_cn&edition=full","pubTime":"2025-06-21 03:40","pubTimestamp":1750448456,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日03时40分,Rallybio Corporation股票出现异动,股价快速下挫5.77%。截至发稿,该股报0.307美元/股,成交量14.2927万股,换手率0.34%,振幅4.60%。Rallybio Corporation股票所在的生物技术行业中,整体跌幅为0.57%。Rallybio Corporation公司简介:Rallybio Corp 是一家临床阶段的生物技术公司,致力于为严重和罕见疾病患者识别和加速开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506210340569788540e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506210340569788540e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLYB","BK4139","BK4539"],"gpt_icon":0},{"id":"2543660917","title":"Rallybio Corporation盘中异动 早盘急速上涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543660917","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543660917?lang=zh_cn&edition=full","pubTime":"2025-06-16 23:20","pubTimestamp":1750087224,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日23时20分,Rallybio Corporation股票出现波动,股价快速拉升5.43%。截至发稿,该股报0.342美元/股,成交量2.4398万股,换手率0.06%,振幅4.94%。Rallybio Corporation股票所在的生物技术行业中,整体跌幅为0.32%。Rallybio Corporation公司简介:Rallybio Corp 是一家临床阶段的生物技术公司,致力于为严重和罕见疾病患者识别和加速开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616232024a4ac60d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616232024a4ac60d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RLYB"],"gpt_icon":0},{"id":"2542510719","title":"Rallybio Corporation盘中异动 早盘快速跳水5.67%报0.336美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542510719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542510719?lang=zh_cn&edition=full","pubTime":"2025-06-12 22:25","pubTimestamp":1749738336,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日22时25分,Rallybio Corporation股票出现异动,股价大幅下跌5.67%。截至发稿,该股报0.336美元/股,成交量6.6021万股,换手率0.16%,振幅3.20%。Rallybio Corporation股票所在的生物技术行业中,整体涨幅为0.43%。Rallybio Corporation公司简介:Rallybio Corp 是一家临床阶段的生物技术公司,致力于为严重和罕见疾病患者识别和加速开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061222253795199a01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061222253795199a01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RLYB"],"gpt_icon":0},{"id":"2542348061","title":"Rallybio Corporation盘中异动 股价大涨6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542348061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542348061?lang=zh_cn&edition=full","pubTime":"2025-06-10 22:28","pubTimestamp":1749565686,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日22时28分,Rallybio Corporation股票出现异动,股价快速上涨6.46%。截至发稿,该股报0.399美元/股,成交量3.0099万股,换手率0.07%,振幅4.54%。Rallybio Corporation股票所在的生物技术行业中,整体涨幅为0.73%。Rallybio Corporation公司简介:Rallybio Corp 是一家临床阶段的生物技术公司,致力于为严重和罕见疾病患者识别和加速开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610222807a4a215d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610222807a4a215d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RLYB","BK4139"],"gpt_icon":0},{"id":"2542333742","title":"Rallybio Corporation盘中异动 早盘急速下挫6.25%报0.370美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542333742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542333742?lang=zh_cn&edition=full","pubTime":"2025-06-09 22:11","pubTimestamp":1749478277,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日22时11分,Rallybio Corporation股票出现异动,股价大幅跳水6.25%。截至发稿,该股报0.370美元/股,成交量1.3291万股,换手率0.03%,振幅2.89%。Rallybio Corporation股票所在的生物技术行业中,整体涨幅为0.34%。Rallybio Corporation公司简介:Rallybio Corp 是一家临床阶段的生物技术公司,致力于为严重和罕见疾病患者识别和加速开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092211179777f0ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092211179777f0ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RLYB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rallybio.com","stockEarnings":[{"period":"1week","weight":0.2209},{"period":"1month","weight":0.1404},{"period":"3month","weight":0.6229},{"period":"6month","weight":-0.5679},{"period":"1year","weight":-0.7159},{"period":"ytd","weight":-0.5769}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rallybio Corporation于2018年3月22日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,由经验丰富的生物制药行业领导者组成,拥有广泛的研究、开发和罕见疾病专业知识,其使命是为患有严重和罕见疾病的患者开发和商业化改变生命的疗法。自公司于2018年1月推出以来,该公司已经建立了广泛的有前景的候选产品管道,旨在解决孕产妇胎儿健康、补体失调、血液学和代谢紊乱等领域存在未满足医疗需求的疾病。该公司两个最先进的项目正在临床开发中:RLYB212,一种用于预防胎儿和新生儿同种免疫性血小板减少症(“FNAIT”)的抗HPA-1a抗体,以及RLYB116,一种补体成分5(“C5”)的抑制剂,具有治疗几种补体失调疾病的潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.052117},{"month":2,"riseRate":0.5,"avgChangeRate":0.149998},{"month":3,"riseRate":0,"avgChangeRate":-0.234376},{"month":4,"riseRate":0.5,"avgChangeRate":-0.025587},{"month":5,"riseRate":0.5,"avgChangeRate":0.132316},{"month":6,"riseRate":0.25,"avgChangeRate":-0.189526},{"month":7,"riseRate":1,"avgChangeRate":0.132847},{"month":8,"riseRate":0.25,"avgChangeRate":-0.081287},{"month":9,"riseRate":0.75,"avgChangeRate":0.074309},{"month":10,"riseRate":0.5,"avgChangeRate":-0.049333},{"month":11,"riseRate":0.25,"avgChangeRate":-0.27145},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011574}],"exchange":"NASDAQ","name":"Rallybio Corp.","nameEN":"Rallybio Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rallybio Corp.(RLYB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rallybio Corp.(RLYB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rallybio Corp.,RLYB,Rallybio Corp.股票,Rallybio Corp.股票老虎,Rallybio Corp.股票老虎国际,Rallybio Corp.行情,Rallybio Corp.股票行情,Rallybio Corp.股价,Rallybio Corp.股市,Rallybio Corp.股票价格,Rallybio Corp.股票交易,Rallybio Corp.股票购买,Rallybio Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rallybio Corp.(RLYB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rallybio Corp.(RLYB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}